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Compliance with continuous positive airway
pressure (CPAP) therapy for obstructive sleep
apnea among privately paying patients- a cross
sectional study
Syed Fayyaz Hussain1, Muhammad Irfan2*, Zeeshan Waheed3, Naveen Alam2, Saba Mansoor2 and Muhammad Islam4
Abstract
Background: To evaluate the compliance, benefits and side effects associated with continuous positive airway
pressure (CPAP) therapy among Pakistani patients treated for obstructive sleep apnea (OSA) in private sector.
Methods: Patients diagnosed to have OSA based on overnight study who were recommended for CPAP therapy,
between 1998 and 2003, were evaluated by telephonic survey and review of hospital notes. Compliance, benefits
and side effects associated with CPAP therapy were assessed.
Results: Out of 135 patients who were prescribed CPAP therapy, 75 could be contacted. Sixty (80%) started using
CPAP within one month of diagnosis and 46 (61%) continued to use it long-term (beyond one year). Compliance
with CPAP therapy was associated with higher body mass index, higher Epworth sleepiness scale score, history of
witnessed apnea, and reduction in daytime sleepiness with CPAP therapy. OSA severity as assessed by apnea-hypopnea
index did not affect compliance with CPAP therapy. Use of anti-depressants and CPAP induced sleep disturbances were
associated with poor compliance with CPAP therapy.
Conclusions: Obesity, excessive daytime sleepiness, witnessed apnea and improvement of daytime symptoms
following use of CPAP were predictors of improved compliance. Use of antidepressants and CPAP induced sleep
disturbances were predictors of poor compliance.
Keywords: Obstructive sleep apnea, Continuous positive airway pressure therapy, Compliance, Side effects, Pakistan
Background
Obstructive sleep apnea (OSA) is relatively common dis-
order with estimated prevalence of 4% in men and 2% in
women [1]. OSA is characterized by intermittent obstruc-
tion of the upper airway during sleep. Patients experience
repetitive episodes of apnea (complete cessation of airflow),
hypopnea (partial reduction in airflow) and oxygen desat-
uration, and sleep fragmentation. Common symptoms are
of loud habitual snoring, frequent nocturnal awakening,
unrefreshing sleep and excessive daytime sleepiness (EDS).
Age, gender, obesity, and nasal blockage are some of the
well-established risk factors for OSA [2]. OSA is associated
with poor sleep quality, impaired cognition and increased
risk of accidents [3]. Furthermore, there is increased risk of
fatal and non-fatal cardiovascular events and the treatment
of OSA favorably reduces the risks associated with OSA
[4]. Similarly, OSA is associated with an increase in blood
pressure that is improved with treating apnea but not by
supplemental O2 therapy suggesting mechanisms other
than hypoxemia are responsible for hypertension [5].
Continuous positive airway pressure (CPAP) therapy is
the treatment of choice for OSA. CPAP therapy produces
improvements in daytime sleepiness and cognitive func-
tion with improved quality of life compared with control
[6]. Good compliance with CPAP therapy has been shown
to achieve cardiovascular and metabolic benefits [7].
Despite the high efficacy of CPAP, treatment effective-
ness is limited by variable adherence to prescribed therapy
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[8]. Failure to comply with CPAP therapy may occur in up
to 25% to 50% patients, with patients typically abandoning
therapy within the first 4 weeks of treatment [9]. In one
review up to 91% of the patients discontinued the CPAP
treatment in the first three years of therapy [10].
The aim of this study was to evaluate the compliance,
benefits and side effects associated with CPAP therapy
among Pakistani patients treated in private sector.
Methods
The study was conducted at The Aga Khan University
Hospital, a private teaching hospital in Karachi, Pakistan.
Patients were diagnosed to have OSA based on suggest-
ive clinical features (habitual snoring, witnessed apnea,
unrefreshing sleep and excessive daytime sleepiness)
and confirmed by an overnight-supervised oximetry or
polysomnography. Two levels of sleep studies were per-
formed; overnight full polysomnography in 55 (73.3%)
and overnight pulse oximetry in 20 (26.7%) patients.
The variables monitored in polysomnography were electro-
encephalogram (EEG), electrooculogram (EOG), chin and
leg electromyogram (EMG), electrocardiogram (ECG),
oronasal airflow (thermistor), oxygen saturation, and
chest and abdominal wall movements (respiratory in-
ductive plethysmograph). In overnight oximetry data
was analysed for number of Oxygen (O2) desaturations,
basal O2 saturation, minimum O2 saturation, cumula-
tive time spent below 90% saturation and O2 desatur-
ation index (total number of O2 desaturation divided by
duration of recording in hrs). Waveform was recorded
for the whole duration of recording as a compact one-
page tracing and in an expanded hourly format for de-
tailed review. Daytime sleepiness was assessed using
Epworth sleepiness scale (ESS) score [11]. Threshold
for treating OSA was apnea-hypopnea index (AHI) > 15
per hour or 3% oxygen desaturation index > 15 per hour
accompanied with daytime symptoms. Nasal CPAP was
initiated following a supervised titration study. Patients
had a session on mask application and machine use.
The patients had to buy their own machine.
The survey was done from January to March 2006.
Patients diagnosed to have OSA between 1998 and
2003 were included in the study. A trained research officer
reviewed their notes and contacted patients by telephone.
As this was the telephonic survey, verbal consent was
taken from all participants. Data was entered using a
structured questionnaire that elicited information about
symptoms, past medical history, drug history, family his-
tory, sleep history, examination findings and results of in-
vestigations. Compliance was assessed by asking multiple
questions on daily day time and night time usage in hours
and period of failure to use of CPAP machine. Benefits
and side effects associated with CPAP therapy were also
assessed.
Improvement in ESS score of two points or more was
considered significant. Compliance was defined as con-
tinued (long-term) use of CPAP therapy beyond one
year. Current smoker was defined as someone who con-
tinues to smoke any amount of tobacco either regularly or
occasionally. A non-smoker was one who has never
smoked and an ex-smoker was someone who had smoked
in the past but had now stopped.
The study was approved by Ethics Review Committee
(ERC) of Aga Khan University.
Statistical analysis
The Statistical Package for social science SPSS version
16.0 was used for data analysis. Descriptive analysis was
done for demographic, clinical and radiographic features.
Results were expressed as mean ± standard deviation for
quantitative variables and number (percentage) for quali-
tative variables. In Univariate analysis difference in means
for compliance and non-compliance were performed by
Independent Sample t-test, where as difference in propor-
tion were assessed by Pearson Chi-square or Fisher’s exact
test where were appropriate. P value less than 0.05 was
considered as statistically significant. All p-value were two
sided.
Results
A total of 135 patients were diagnosed to have OSA be-
tween 1998 and 2003. At the time of survey, 75 (55.5%)
patients (60 males) had a valid contact detail and were
contacted. The base line characteristics of patients of
OSA with and without valid contact is presented in
Table 1.
Out of 75 patients who had a valid contact, continuous
positive airway pressure therapy was started by 60 (80%)
patients within one month of prescription and 46 (61.3%)
continued to use CPAP therapy beyond one year. 56/75
(75%) patients used the machine for over 5 hours each
night. CPAP was perceived as a satisfactory treatment by
50 (67%), not satisfactory by 7 (9%) while 18 (24%) were
not sure about it. Subjective improvement in snoring was
reported by 51 (68%) and in daytime performance by 54
(72%). Objective improvement in Epworth sleepiness scale
score was recorded in 54 (72%).
Side effects associated with CPAP therapy were minor
but frequent. These included skin changes in 31 (41%),
sleep disturbance in 19 (25%), poor mask fit in 15 (20%),
eye irritation in 13 (17%), ear symptoms in 9 (12%) and
flatulence in 10 (13%).
Factors associated with compliance
On univariate analysis age, gender, history of snoring, pres-
ence of comorbid conditions or smoking status, mask re-
lated side effects, OSA severity (as assessed by AHI index)
did not affect compliance with CPAP therapy. However,
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higher body mass index, higher ESS score at baseline,
higher prevalence of witnessed apnea, improvements in
daytime activity and improvement in ESS score were posi-
tively associated with compliance with CPAP therapy,
while CPAP induced sleep disturbance was associated with
non-compliance with CPAP therapy (Table 2).
Discussion
Privately paying Pakistani patients who had a valid con-
tact (75/135) at the time of study with obstructive sleep
apnea had 80% (60/75) initial acceptance of CPAP ther-
apy and 61.3% (46/75) continued to use CPAP therapy
beyond one year. This initial compliance rate was similar
to that reported in western studies [12]. Long-term com-
pliance with CPAP therapy varied between countries,
lower compliance rates were reported in North America
compared to Europe [12].
Studies on CPAP compliance in ethnic groups are lim-
ited. In a Chinese study, 33% never commenced CPAP
therapy [13]. Even lower compliance rate (36%) was ob-
served among bus drivers in Hong Kong despite signifi-
cant improvement in subjective sleepiness and cognitive
function with CPAP therapy [14]. In a study from USA,
CPAP adherence was low in black subjects [15]. Simi-
larly Maori subjects had lower adherence to CPAP ther-
apy than Maori subjects that was thought to be related
to lower educational levels and socioeconomic status
[16]. Thus, differences in compliance with CPAP therapy
were multifactorial such as ethnicity, educational and so-
cioeconomic status, and differences in treatment facil-
ities and follow-up.
Differences in compliance may occur in patients being
treated in private and public sectors. This aspect of
CPAP therapy has not been studied in detail. In a study
from Brazil [17], patients in private sector had more
greater severity of OSA than patients in public sector
(AHI 31 ± 25 vs. 25 ± 24, p < 0.001) but CPAP acceptance
was similar in both sectors (32 vs. 35%). This acceptance
rate was much lower than that observed in our cohort of
private sector patients as well. In Pakistan the health
care facilities in public sector are suboptimal and inad-
equate resources are available to provide top quality
healthcare provision. The peoples who seek these facil-
ities are mainly from low socio-economic groups. The
sleep study facilities were not available in most of the
public sector hospitals of Pakistan at the time of study
and they referred all these patients to private sector hos-
pitals. When we did this study not a single public sector
hospital offer diagnosis and treatment facility in the city.
This is one of the major reason and a limitation that we
are unable to compare our cohort with public sector
cohort.
In our study the long-term compliance with CPAP
therapy was 61% among all OSA patients but 76%
among those who initially accepted CPAP. In a study
from UK, 77% were still using CPAP at three years and
median use of CPAP in those continuing therapy was
5.3 hours/night [18]. In another UK-based study of over
1000 OSA patients, 4.5% patients refused CPAP treatment
Table 1 The base line characteristics of patients of
Obstructive sleep apnea with and without valid contact
Characteristics Valid contact
(n = 75)
Without valid
contact (n = 60)
P-value
Sex:
Male 60 (80%) 49 (82%) 0.83
Female 15 (20%) 11 (18%)
Age (mean) ± SD years 52.9 ± 12.1 50.23 ± 14.0 0.41
BMI 35.89 ± 10.75 36.4 ± 8.23 0.86
Collar size (cm) 35.9 ± 14.4 35.1 ± 11.7 0.9
ESS 15.8 ± 5.6 15.2 ± 8.4 0.87
Smoking status:
Current smoker 16 (21%) 18 (30%)
Ex-smoker 19 (25%) 16 (27%) 0.42
Non smoker 40 (54%) 26 (43%)
Associated comorbidities
Hypertension 42 (57%) 21 (35%) 0.01
Diabetes 21 (28%) 18 (30%) 0.85
Ischemic heart disease 20 (27%) 14 (23%) 0.69
Dyslipidemia 10 (14%) 13 (21%) 0.25
COPD 08 (11%) 10 (16%) 0.32
History of nasal surgery 11 (15%) 08 (13%) 0.99
BMI = body mass index, ESS = Epworth sleepiness scale, COPD = chronic
obstructive pulmonary disease.
Table 2 Factors associated with compliance with CPAP
therapy beyond one year in Pakistani patients on
univariate analysis
Factors Compliant Non-Compliant p-value
(n = 46) (n = 29)
Affecting increasing
compliance with
CPAP therapy
BMI (kg/m2) 38.2 ± 11.9 31.7 ± 6.5 0.015
ESS score before CPAP 17.5 ± 4.1 12.6 ± 6.7 0.005
Witnessed apnea before CPAP 33 (72%) 7 (30%) 0.001
Improved daytime activity
with CPAP
43 (94%) 11 (73%) 0.05
ESS score improved with CPAP 43 (94%) 11 (73%) 0.05
Affecting non-compliance
with CPAP therapy
Sleep disturbance with CPAP 9 (20%) 10 (67%) 0.001
BMI = body mass index, CPAP = continuous positive airway pressure,
ESS = Epworth sleepiness scale.
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(these were more often female and current smokers) and
during follow-up 20% stopped treatment, primarily be-
cause of a lack of benefit. Methods of survival analysis
showed that 68% of patients continued treatment at 5 year
[19]. The compliance was higher (86%) among those with
severe OSA (AHI > 30/hr) accompanied with daytime
sleepiness. Among a cohort of 109 German patients
treated with CPAP, only 46.6% met stringent criteria for
long-term compliance, defined as a mean use of the CPAP
machine for at least 5 hours per night [20]. In Canada,
using a population-based CPAP program consisting of
consistent follow-up, “troubleshooting”, and regular feed-
back to both patients and physicians CPAP compliance
rates of greater than 85% over 6 months was achieved
[21]. In our set up, choice of nasal interface was limited,
patients often had to travel long distances and the onus of
follow-up remained with the patient. Despite these limita-
tions a long-term compliance of above 60% was seen.
Factors associated with compliance with CPAP therapy
are manifold. These include patient characteristics, symp-
toms, psychological factors, sleep study variables, response
to therapy, side effects, cost of treatment, expertise avail-
able, and use of interventions and educational strategies
to improve compliance with treatment. In our study, OSA
severity as assessed by AHI did not correlate with a better
compliance. Similar findings were reported from USA and
UK, in which long-term compliance was not associated
with AHI severity but with daytime symptoms [22] or
negatively with side effects associated with CPAP therapy
[23]. However, other studies have shown a positive associ-
ation between compliance and severity of OSA as assessed
by AHI [24,25]. Age and gender were not associated with
compliance with CPAP therapy in our study, and variable
results have been reported in literature [21,25].
In our study use of anti-depressant was associated
poor compliance with CPAP therapy. This was in keep-
ing with other studies showing that psychological factors
contributed partly to compliance with therapy [26]. High
anxiety and depression score were associated with poor
compliance with CPAP therapy [27]. Recent life-events
and living alone were also associated with lower machine
use [28].
Patients who experience side effects from CPAP ma-
chine are less likely to comply with therapy but the na-
ture of side effects that impacts compliance have varied
between studies [21,23,25]. In our study, sleep disturb-
ance associated with the use of CPAP therapy was
strongly associated with poor compliance with therapy.
In our study, long-term compliance with CPAP ther-
apy was better in those patients who achieved an im-
provement in daytime symptoms. CPAP therapy was
perceived as an effective treatment by majority (67%) of
our patients, similar to finding from Toronto study
where 81% perceived CPAP as an effective treatment
[29]. Improvement in ESS score was associated with bet-
ter compliance in one study [21], but improvement in
multiple sleep latency in another study was not associ-
ated with higher CPAP usage [23].
There are certain limitations of our study. First there
is a small sample size and we have only valid contact of
75 out of 135 patients. The most important reason for
this level of dropout is that most of the patients give
their cell phone numbers for contact and there is a very
common practice and habit of our population that they
change their cell phone numbers and services very fre-
quently. As this is a single center study and most of the
patients with and without valid contact are from the
same background so that we can assume that the level
of withdrawal would also be same in patients without a
valid contact. Second we use telephone survey to assess
the compliance of CPAP therapy. We know that there
are some problems for precise evaluation for this
method and now newer CPAP machine has built-in-
capabilities of keeping record of day and night usage.
During the study period these types of machines were
not available in Pakistan and almost all of the patients
use machines without these facilities. We try to over-
come this shortcoming by asking multiple questions on
compliance by using a preformed detailed structured
questionnaire. Future studies using records of CPAP ma-
chine would be more reliable regarding compliance of
CPAP usage. We use only univariate analysis with a
small sample size is another limitation and studies with
larger sample size with logistic regression analysis would
be more helpful.
Conclusion
In conclusion, privately paying Pakistani patients were able
to achieve similar level of compliance with CPAP therapy
as in other countries. Severity of OSA symptoms at presen-
tation and benefit from treatment predicted higher compli-
ance with CPAP therapy. Severity of OSA as assessed by
sleep study did not affect compliance with therapy.
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